Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

314 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 314 results

Early research (Phase 1)Study completedNCT00731952
What this trial is testing

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Virginia 21
Early research (Phase 1)Study completedNCT07504484
What this trial is testing

Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer

Who this might be right for
CRC (Colorectal Cancer)Non Small Lung Cancer
Ying Yuan, MD 6
Testing effectiveness (Phase 2)Looking for participantsNCT07122687
What this trial is testing

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 170
Early research (Phase 1)WithdrawnNCT01637376
What this trial is testing

Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung
University of Arkansas
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Testing effectiveness (Phase 2)WithdrawnNCT05472623
What this trial is testing

Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab

Who this might be right for
Resectable Non-Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT04302025
What this trial is testing

Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159
What this trial is testing

NADIM II: Neo-Adjuvant Immunotherapy

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 90
Testing effectiveness (Phase 2)WithdrawnNCT02662634
What this trial is testing

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
GU Research Network, LLC
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Large-scale testing (Phase 3)Looking for participantsNCT06598527
What this trial is testing

Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study

Who this might be right for
Lung Cancer (NSCLC)
Yang Hong 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946836
What this trial is testing

Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study

Who this might be right for
Resectable Non-small Cell Lung CancerBispecific AntibodyNeoadjuvant Therapy
Shanghai Pulmonary Hospital, Shanghai, China 80
Early research (Phase 1)Ended earlyNCT02987998
What this trial is testing

Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
Nathan Pennell, MD, PhD 9
Not applicableStudy completedNCT03824977
What this trial is testing

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Who this might be right for
Lung Neoplasm MalignantResectable Lung Non-Small Cell Carcinoma
University Hospital, Rouen 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT04326153
What this trial is testing

Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer

Who this might be right for
IIIA Stage Non-small Cell Lung Cancer
The First Hospital of Jilin University 30
Testing effectiveness (Phase 2)Study completedNCT01076231
What this trial is testing

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Post-approval studies (Phase 4)Not Yet RecruitingNCT06893354
What this trial is testing

Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics

Who this might be right for
NSCLC
The First Affiliated Hospital of Guangzhou Medical University 20
Large-scale testing (Phase 3)UnknownNCT04968002
What this trial is testing

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT02994576
What this trial is testing

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 60
Next Page